Literature DB >> 22415610

Drug-induced hallucinatory syndrome in a patient with breast cancer after paclitaxel infusion.

L Slovacek, B Slovackova.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22415610     DOI： 10.1007/s00520-012-1438-3

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  5 in total

1.  Integrin-targeted paclitaxel nanoliposomes for tumor therapy.

Authors:  Shuyan Meng; Bo Su; Wei Li; Yongmei Ding; Liang Tang; Wei Zhou; Yin Song; Zhou Caicun
Journal:  Med Oncol       Date:  2010-07-20       Impact factor: 3.064

2.  Burden of chemotherapy-induced neuropathy--a cross-sectional study.

Authors:  Anna-Liisa Kautio; Maija Haanpää; Hannu Kautiainen; Eija Kalso; Tiina Saarto
Journal:  Support Care Cancer       Date:  2010-11-16       Impact factor: 3.603

Review 3.  Managing taxane toxicities.

Authors:  Maurie Markman
Journal:  Support Care Cancer       Date:  2002-10-15       Impact factor: 3.603

4.  Plasma alcohol concentrations in patients following paclitaxel infusion.

Authors:  L K Webster; N A Crinis; C G Morton; M J Millward
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

Review 5.  Taxol: the first of the taxanes, an important new class of antitumor agents.

Authors:  E K Rowinsky; N Onetto; R M Canetta; S G Arbuck
Journal:  Semin Oncol       Date:  1992-12       Impact factor: 4.929
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.